Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) (1) (iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D dated July 30, 2010 (including amendments thereto) with respect to the Common Stock, par value $0.01 per share, of Advanced Life Sciences Holdings, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Date: July 30, 2010
| Michael T. Flavin, Ph.D. | |
|
|
|
| By: | /s/ Michael T. Flavin |
|
| Name: Michael T. Flavin, Ph.D. |
|
|
|
|
|
|
| John L. Flavin | |
|
| |
| By: | /s/ John L. Flavin |
|
| Name: John L. Flavin |
|
|
|
|
|
|
| Flavin Ventures, LLC | |
|
|
|
| By: | /s/ Michael T. Flavin |
|
| Name: Michael T. Flavin, Ph.D. |
|
| Title: Manager |
|
|
|
| ALS Ventures, LLC | |
|
|
|
| By: Flavin Ventures, LLC, its sole member | |
|
|
|
| By: | /s/ Michael T. Flavin |
|
| Name: Michael T. Flavin, Ph.D. |
|
| Title: Manager |